-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Initiates Coverage On Haemonetics with Outperform Rating, Announces Price Target of $87

Benzinga·06/26/2025 12:56:59
Listen to the news
Baird analyst David Rescott initiates coverage on Haemonetics (NYSE:HAE) with a Outperform rating and announces Price Target of $87.